Mohr Gregoriussen Angelica Maria, Bohr Henrik Georg
Center for the Philosophy of Nature and Science Studies (CPNSS), University of Copenhagen , Copenhagen , Denmark.
Department of Chemistry, The Technical University of Denmark , Lyngby , Denmark.
Front Immunol. 2017 Feb 21;8:9. doi: 10.3389/fimmu.2017.00009. eCollection 2017.
Donor-specific blood transfusion (DST) can lead to significant prolongation of allograft survival in experimental animal models and sometimes human recipients of solid organs. The mechanisms responsible for the beneficial effect on graft survival have been a topic of research and debate for decades and are not yet fully elucidated. Once we discover how the details of the mechanisms involved are linked, we could be within reach of a procedure making it possible to establish donor-specific tolerance with minimal or no immunosuppressive medication. Today, it is well established that CD4+Foxp3+ regulatory T cells (Tregs) are indispensable for maintaining immunological self-tolerance. A large number of animal studies have also shown that Tregs are essential for establishing and maintaining transplantation tolerance. In this paper, we present a hypothesis of one H2-haplotype-matched DST-induced transplantation tolerance (in mice). The formulated hypothesis is based on a re-interpretation of data from an immunogenetic experiment published by Niimi and colleagues in 2000. It is of importance that the naïve recipient mice in this study were never immunosuppressed and were therefore fully immune competent during the course of tolerance induction. Based on the immunological status of the recipients, we suggest that one H2-haplotype-matched self-specific Tregs derived from the transfusion blood can be activated and multiply in the host by binding to antigen-presenting cells presenting allopeptides in their major histocompatibility complex (MHC) class II (MHC-II). We also suggest that the endothelial and epithelial cells within the solid organ allograft upregulate the expression of MHC-II and attract the expanded Treg population to suppress inflammation within the graft. We further suggest that this biological process, here termed MHC-II recruitment, is a vital survival mechanism for organs (or the organism in general) when attacked by an immune system.
供体特异性输血(DST)可使实验动物模型中的同种异体移植物存活期显著延长,在某些情况下也可使实体器官的人类受者的移植物存活期延长。几十年来,DST对移植物存活产生有益影响的机制一直是研究和争论的话题,尚未完全阐明。一旦我们发现其中涉及的机制细节是如何关联的,我们可能就能够找到一种方法,在使用最少或不使用免疫抑制药物的情况下建立供体特异性耐受性。如今,人们已经充分认识到,CD4+Foxp3+调节性T细胞(Tregs)对于维持免疫自身耐受性是不可或缺的。大量动物研究也表明,Tregs对于建立和维持移植耐受性至关重要。在本文中,我们提出了一个关于一种H2单倍型匹配的DST诱导移植耐受性(在小鼠中)的假说。所提出的假说基于对Niimi及其同事在2000年发表的一项免疫遗传学实验数据的重新解读。重要的是,本研究中的未致敏受体小鼠从未接受过免疫抑制,因此在耐受性诱导过程中具有完全的免疫能力。基于受体的免疫状态,我们认为,来自输血血液的一种H2单倍型匹配的自身特异性Tregs可通过与在其主要组织相容性复合体(MHC)II类(MHC-II)中呈递异源肽的抗原呈递细胞结合,在宿主体内被激活并增殖。我们还认为,实体器官同种异体移植物内的内皮细胞和上皮细胞会上调MHC-II的表达,并吸引扩增的Treg群体来抑制移植物内的炎症。我们进一步认为,这一生物学过程,在此称为MHC-II募集,是器官(或整个生物体)在受到免疫系统攻击时至关重要的存活机制。